SPATA21
gene geneOn this page
Also known as spergen-2spergen2
Summary
SPATA21 (spermatogenesis associated 21, HGNC:28026) is a protein-coding gene on chromosome 1p36.13, encoding Spermatogenesis-associated protein 21 (Q7Z572). Involved in the differentiation of haploid spermatids.
Predicted to enable calcium ion binding activity.
Source: NCBI Gene 374955 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 85 total
- MANE Select transcript:
NM_198546
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28026 |
| Approved symbol | SPATA21 |
| Name | spermatogenesis associated 21 |
| Location | 1p36.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | spergen-2, spergen2 |
| Ensembl gene | ENSG00000187144 |
| Ensembl biotype | protein_coding |
| Entrez | 374955 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 5 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000335496, ENST00000375577, ENST00000466212, ENST00000491418, ENST00000540400, ENST00000612240
RefSeq mRNA: 2 — MANE Select: NM_198546
NM_001353349, NM_198546
CCDS: CCDS172, CCDS85935
Canonical transcript exons
ENST00000335496 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001333360 | 16398643 | 16398822 |
| ENSE00001333382 | 16421509 | 16421557 |
| ENSE00001333383 | 16421911 | 16421971 |
| ENSE00001333384 | 16431338 | 16431422 |
| ENSE00001333385 | 16432790 | 16432924 |
| ENSE00001333388 | 16437128 | 16437424 |
| ENSE00003563521 | 16403968 | 16404039 |
| ENSE00003583615 | 16400720 | 16400892 |
| ENSE00003608567 | 16409601 | 16410043 |
| ENSE00003622122 | 16399344 | 16399521 |
| ENSE00003652032 | 16403727 | 16403844 |
| ENSE00003655553 | 16409118 | 16409203 |
| ENSE00003689057 | 16404967 | 16405104 |
Expression profiles
Bgee: expression breadth ubiquitous, 144 present calls, max score 92.59.
Top tissues by expression
191 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 92.59 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 86.96 | gold quality |
| vena cava | UBERON:0004087 | 85.01 | silver quality |
| tendon of biceps brachii | UBERON:0008188 | 84.95 | silver quality |
| myocardium | UBERON:0002349 | 83.42 | silver quality |
| vastus lateralis | UBERON:0001379 | 80.35 | silver quality |
| sperm | CL:0000019 | 80.27 | gold quality |
| quadriceps femoris | UBERON:0001377 | 80.25 | silver quality |
| biceps brachii | UBERON:0001507 | 79.22 | silver quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 78.94 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.55 | gold quality |
| gingival epithelium | UBERON:0001949 | 78.31 | gold quality |
| superficial temporal artery | UBERON:0001614 | 77.34 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 77.32 | silver quality |
| parotid gland | UBERON:0001831 | 76.99 | gold quality |
| deltoid | UBERON:0001476 | 76.55 | silver quality |
| cerebellar vermis | UBERON:0004720 | 75.55 | silver quality |
| body of tongue | UBERON:0011876 | 75.53 | silver quality |
| right testis | UBERON:0004534 | 74.83 | gold quality |
| cardia of stomach | UBERON:0001162 | 74.65 | silver quality |
| left testis | UBERON:0004533 | 74.53 | gold quality |
| nipple | UBERON:0002030 | 74.47 | silver quality |
| nasal cavity epithelium | UBERON:0005384 | 74.43 | gold quality |
| tongue | UBERON:0001723 | 74.42 | silver quality |
| trachea | UBERON:0003126 | 74.36 | silver quality |
| mucosa of sigmoid colon | UBERON:0004993 | 74.17 | silver quality |
| esophagus squamous epithelium | UBERON:0006920 | 73.69 | gold quality |
| decidua | UBERON:0002450 | 73.35 | gold quality |
| testis | UBERON:0000473 | 73.25 | gold quality |
| pylorus | UBERON:0001166 | 73.04 | silver quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.52 |
| E-ENAD-17 | no | 123.32 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
2 targeting SPATA21, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6882-3P | 98.23 | 67.01 | 1119 |
| HSA-MIR-4694-5P | 94.62 | 65.39 | 532 |
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:ch211-197n1.2 | ENSDARG00000042937 |
| mus_musculus | Spata21 | ENSMUSG00000045004 |
| rattus_norvegicus | Spata21 | ENSRNOG00000009058 |
| drosophila_melanogaster | TpnC47D | FBGN0010423 |
| drosophila_melanogaster | TpnC73F | FBGN0010424 |
| drosophila_melanogaster | TpnC41C | FBGN0013348 |
Paralogs (5): CAPS (ENSG00000105519), PHF24 (ENSG00000122733), CAPSL (ENSG00000152611), CAPS2 (ENSG00000180881), EFCAB6 (ENSG00000186976)
Protein
Protein identifiers
Spermatogenesis-associated protein 21 — Q7Z572 (reviewed: Q7Z572)
All UniProt accessions (3): Q7Z572, H7C5T0, Q5VXG6
UniProt curated annotations — full annotation on UniProt →
Function. Involved in the differentiation of haploid spermatids.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q7Z572-1 | 1 | yes |
| Q7Z572-2 | 2 |
RefSeq proteins (2): NP_001340278, NP_940948* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002048 | EF_hand_dom | Domain |
| IPR011992 | EF-hand-dom_pair | Homologous_superfamily |
| IPR018247 | EF_Hand_1_Ca_BS | Binding_site |
| IPR043520 | SPT21 | Family |
UniProt features (23 total): compositionally biased region 5, binding site 5, sequence variant 5, region of interest 3, chain 1, domain 1, splice variant 1, sequence conflict 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z572-F1 | 59.65 | 0.19 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (5): 268; 270; 272; 274; 279
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 10 (showing top):
chr1p36, FIGUEROA_AML_METHYLATION_CLUSTER_3_DN, GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_UP, GSE27786_LIN_NEG_VS_MONO_MAC_DN, GSE27786_BCELL_VS_NEUTROPHIL_DN, GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN, GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_DN, GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP, GSE34515_CD16_NEG_VS_POS_MONOCYTE_UP, GOMF_CALCIUM_ION_BINDING
GO Biological Process (0):
GO Molecular Function (2): calcium ion binding (GO:0005509), metal ion binding (GO:0046872)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| metal ion binding | 1 |
| cation binding | 1 |
Protein interactions and networks
STRING
1355 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPATA21 | OR1L3 | Q8NH93 | 571 |
| SPATA21 | SPATA3 | Q8NHX4 | 510 |
| SPATA21 | SPATA24 | Q86W54 | 503 |
| SPATA21 | CLBA1 | Q96F83 | 490 |
| SPATA21 | DNAJC4 | Q9NNZ3 | 463 |
| SPATA21 | OAZ3 | Q9UMX2 | 427 |
| SPATA21 | ADAM32 | Q8TC27 | 374 |
| SPATA21 | SPATS2 | Q86XZ4 | 365 |
| SPATA21 | SOX17 | Q9H6I2 | 364 |
| SPATA21 | SLC35A5 | Q9BS91 | 354 |
| SPATA21 | JADE3 | Q92613 | 351 |
| SPATA21 | ODF1 | Q14990 | 349 |
| SPATA21 | ANKEF1 | Q9NU02 | 349 |
| SPATA21 | NDUFAF6 | Q330K2 | 305 |
| SPATA21 | SETBP1 | Q9Y6X0 | 303 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CAND1 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (2): SPATA21 (Affinity Capture-RNA), SPATA21 (Affinity Capture-MS)
ESM2 similar proteins: A2ADZ8, A6NNH2, D2J0Y4, D3YU32, P0C2Y1, Q0VET5, Q12802, Q14676, Q149B8, Q283Q6, Q2TBI7, Q3KR64, Q3U0P1, Q4KMZ1, Q4R736, Q5QJ38, Q5R5G4, Q5T1N1, Q5TM68, Q5VWK0, Q5VYM1, Q5ZK13, Q68A65, Q6AZ54, Q6NXZ1, Q6PG16, Q6PIX9, Q7YR40, Q7Z572, Q86Y26, Q8BHP2, Q8BHW6, Q8C0D9, Q8C5V8, Q8C9M2, Q8CGM2, Q8N5Q1, Q8NCD3, Q8WP21, Q924C5
Diamond homologs: O74435, P02597, P04464, P05419, P13868, P15845, P25071, P27161, P27163, Q0IQB6, Q0IUU4, Q2T9P0, Q40302, Q41420, Q4R736, Q66HC0, Q68A65, Q7Z572, Q80X60, Q84MN0, Q8BHW6, Q8K4K1, Q8N7B9, Q9LE22, A3E3H0, A3E4D8, A3E4F9, A4UHC0, A8I1Q0, O02367, O16305, O82018, O82659, O96081, O97341, P02591, P02598, P02599, P04352, P07463
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
85 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 68 |
| Likely benign | 8 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2932 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:16393478:GACAG:G | donor_gain | 1.0000 |
| 1:16393479:ACAG:A | donor_gain | 1.0000 |
| 1:16393479:ACAGG:A | donor_loss | 1.0000 |
| 1:16393480:CAGG:C | donor_loss | 1.0000 |
| 1:16393481:AG:A | donor_gain | 1.0000 |
| 1:16393482:GG:G | donor_gain | 1.0000 |
| 1:16393482:GGTG:G | donor_loss | 1.0000 |
| 1:16393483:G:GA | donor_loss | 1.0000 |
| 1:16393483:G:GG | donor_gain | 1.0000 |
| 1:16393484:T:A | donor_loss | 1.0000 |
| 1:16400716:TCACC:T | donor_loss | 1.0000 |
| 1:16400717:CAC:C | donor_loss | 1.0000 |
| 1:16400718:A:AC | donor_gain | 1.0000 |
| 1:16400719:C:CC | donor_gain | 1.0000 |
| 1:16400893:C:CC | acceptor_gain | 1.0000 |
| 1:16403725:A:AC | donor_gain | 1.0000 |
| 1:16403726:C:CC | donor_gain | 1.0000 |
| 1:16403736:T:TA | donor_gain | 1.0000 |
| 1:16404962:CTCA:C | donor_loss | 1.0000 |
| 1:16404963:TCACC:T | donor_loss | 1.0000 |
| 1:16404965:A:AC | donor_gain | 1.0000 |
| 1:16404965:AC:A | donor_gain | 1.0000 |
| 1:16404966:C:CA | donor_gain | 1.0000 |
| 1:16404966:CC:C | donor_gain | 1.0000 |
| 1:16404966:CCA:C | donor_gain | 1.0000 |
| 1:16405100:GAAGG:G | acceptor_gain | 1.0000 |
| 1:16405101:AAGG:A | acceptor_gain | 1.0000 |
| 1:16405102:AGG:A | acceptor_gain | 1.0000 |
| 1:16405103:GG:G | acceptor_gain | 1.0000 |
| 1:16405105:C:CC | acceptor_gain | 1.0000 |
AlphaMissense
3052 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:16404011:G:C | F280L | 0.989 |
| 1:16404011:G:T | F280L | 0.989 |
| 1:16404013:A:G | F280L | 0.989 |
| 1:16404012:A:G | F280S | 0.984 |
| 1:16405088:A:C | F230L | 0.984 |
| 1:16405088:A:T | F230L | 0.984 |
| 1:16405090:A:G | F230L | 0.984 |
| 1:16403792:A:C | F312L | 0.982 |
| 1:16403792:A:T | F312L | 0.982 |
| 1:16403794:A:G | F312L | 0.982 |
| 1:16405101:A:G | F226S | 0.979 |
| 1:16405100:G:C | F226L | 0.975 |
| 1:16405100:G:T | F226L | 0.975 |
| 1:16405102:A:G | F226L | 0.975 |
| 1:16403981:G:C | F290L | 0.973 |
| 1:16403981:G:T | F290L | 0.973 |
| 1:16403983:A:G | F290L | 0.973 |
| 1:16404020:G:C | F277L | 0.972 |
| 1:16404020:G:T | F277L | 0.972 |
| 1:16404022:A:G | F277L | 0.972 |
| 1:16403757:A:G | L324S | 0.971 |
| 1:16405047:A:G | L244P | 0.968 |
| 1:16400888:A:C | Y336D | 0.966 |
| 1:16409933:G:C | F85L | 0.966 |
| 1:16409933:G:T | F85L | 0.966 |
| 1:16409935:A:G | F85L | 0.966 |
| 1:16403994:T:A | D286V | 0.963 |
| 1:16405093:A:C | Y229D | 0.960 |
| 1:16403733:A:C | I332S | 0.958 |
| 1:16403793:A:G | F312S | 0.956 |
dbSNP variants (sampled 300 via entrez): RS1000015713 (1:16411034 A>G), RS1000107244 (1:16409282 C>G,T), RS1000171612 (1:16408175 G>T), RS1000178275 (1:16425962 T>C,G), RS1000244200 (1:16422957 G>T), RS1000315739 (1:16422482 A>G), RS1000338045 (1:16432248 A>G), RS1000392928 (1:16438562 T>C), RS1000560881 (1:16409122 C>G,T), RS1000573177 (1:16435409 C>T), RS1000660260 (1:16402179 C>T), RS1000733415 (1:16401966 T>G), RS1000876134 (1:16415156 G>A,C), RS1000920820 (1:16407025 G>A), RS1001078230 (1:16433668 C>A,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid | affects methylation, increases abundance | 1 |
| sodium arsenite | decreases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| Cannabinoids | increases abundance, affects methylation | 1 |
| Methapyrilene | decreases methylation | 1 |
| Urethane | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.